Side effects of long-term amiodarone therapy.
1983; Lippincott Williams & Wilkins; Volume: 67; Issue: 1 Linguagem: Inglês
10.1161/01.cir.67.1.45
ISSN1524-4539
AutoresLouise Harris, William J. McKenna, Edward Rowland, David W. Holt, G. Storey, D M Krikler,
Tópico(s)Ion channel regulation and function
ResumoHomeCirculationVol. 67, No. 1Side effects of long-term amiodarone therapy. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBSide effects of long-term amiodarone therapy. L Harris, W J McKenna, E Rowland, D W Holt, G C Storey and D M Krikler L HarrisL Harris , W J McKennaW J McKenna , E RowlandE Rowland , D W HoltD W Holt , G C StoreyG C Storey and D M KriklerD M Krikler Originally published1 Jan 1983https://doi.org/10.1161/01.CIR.67.1.45Circulation. 1983;67:45–51 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Brooks J, Howland K, Coury L and Dyalram D (2022) Wolff–Parkinson–White syndrome: Review of published cases associated with head and neck/oral and maxillofacial procedures, Oral Surgery, 10.1111/ors.12715, 15:4, (672-680), Online publication date: 1-Nov-2022. Sarkar R, Choubey V and Devadasan S (2022) Hyperpigmentary Skin Disorders Atlas of Dermatology, Dermatopathology and Venereology, 10.1007/978-3-319-53808-2_38, (223-241), . Kowalska J, Rok J, Rzepka Z and Wrześniok D (2021) Drug-Induced Photosensitivity—From Light and Chemistry to Biological Reactions and Clinical Symptoms, Pharmaceuticals, 10.3390/ph14080723, 14:8, (723) Feduska E, Thoma B, Torjman M and Goldhammer J (2021) Acute Amiodarone Pulmonary Toxicity, Journal of Cardiothoracic and Vascular Anesthesia, 10.1053/j.jvca.2020.10.060, 35:5, (1485-1494), Online publication date: 1-May-2021. Algharably E, Di Consiglio E, Testai E, Kreutz R and Gundert-Remy U (2021) Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro–in vivo extrapolation, Archives of Toxicology, 10.1007/s00204-021-02989-2, 95:4, (1433-1442), Online publication date: 1-Apr-2021. Rath B, Köbe J, Reinke F and Eckardt L (2021) Reduzierter biventrikulärer Stimulationsanteil durch ExtrasystolenManagement of premature ventricular ectopy in cardiac resynchronization therapy, Herzschrittmachertherapie + Elektrophysiologie, 10.1007/s00399-021-00745-8, 32:1, (41-47), Online publication date: 1-Mar-2021. Mulder B, Rienstra M and Blaauw Y (2020) Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction, Heart, 10.1136/heartjnl-2020-317491, 107:1, (10-17), Online publication date: 1-Jan-2021. Lozzi F, Di Raimondo C, Lanna C, Diluvio L, Mazzilli S, Garofalo V, Dika E, Dellambra E, Coniglione F, Bianchi L and Campione E (2020) Latest Evidence Regarding the Effects of Photosensitive Drugs on the Skin: Pathogenetic Mechanisms and Clinical Manifestations, Pharmaceutics, 10.3390/pharmaceutics12111104, 12:11, (1104) Leao Filho H, de Oliveira C and Horvat N (2020) Other types of diffuse liver disease: is there a way to do it?, Abdominal Radiology, 10.1007/s00261-020-02530-6, 45:11, (3425-3443), Online publication date: 1-Nov-2020. Gudbjartsson T, Helgadottir S, Sigurdsson M, Taha A, Jeppsson A, Christensen T and Riber L (2019) New‐onset postoperative atrial fibrillation after heart surgery, Acta Anaesthesiologica Scandinavica, 10.1111/aas.13507, 64:2, (145-155), Online publication date: 1-Feb-2020. Sarkar R, Choubey V and Devadasan S (2020) Hyperpigmentary Skin Disorders Atlas of Dermatology, Dermatopathology and Venereology, 10.1007/978-3-319-45134-3_38-1, (1-20), . Ruzieh M, Moroi M, Aboujamous N, Ghahramani M, Naccarelli G, Mandrola J and Foy A (2019) Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo, The American Journal of Cardiology, 10.1016/j.amjcard.2019.09.008, 124:12, (1889-1893), Online publication date: 1-Dec-2019. Filgueira C, Igo S, Wang D, Hirsch M, Schulz D, Bruckner B and Grattoni A (2019) Technologies for intrapericardial delivery of therapeutics and cells, Advanced Drug Delivery Reviews, 10.1016/j.addr.2019.02.006, 151-152, (222-232), Online publication date: 1-Nov-2019. Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J and Lafuente-Lafuente C (2019) Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005049.pub5, 2019:9 Abu-Helalah M, Alshraideh H, Al-Sarayreh S, al Shawabkeh A, Nesheiwat A, Younes N and AL-Hader A (2019) A Cross-Sectional Study to Assess the Prevalence of Adult Thyroid Dysfunction Disorders in Jordan, Thyroid, 10.1089/thy.2018.0579, 29:8, (1052-1059), Online publication date: 1-Aug-2019. Blakely K, Drucker A and Rosen C (2019) Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management, Drug Safety, 10.1007/s40264-019-00806-5, 42:7, (827-847), Online publication date: 1-Jul-2019. AlTurki A, Proietti R, Russo V, Dhanjal T, Banerjee P and Essebag V (2019) Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients, Pharmacological Research, 10.1016/j.phrs.2019.03.020, 143, (133-142), Online publication date: 1-May-2019. Lee A, Walters T, Gerstenfeld E and Haqqani H (2019) Frequent Ventricular Ectopy: Implications and Outcomes, Heart, Lung and Circulation, 10.1016/j.hlc.2018.09.009, 28:1, (178-190), Online publication date: 1-Jan-2019. Balaji S, Mandapati R and Webb G (2019) Fontan Patient With Brady and Tachyarrhythmia Issues Arrhythmias in Adult Congenital Heart Disease, 10.1016/B978-0-323-48568-5.00010-X, (77-91), . Sanes D, Reh T, Harris W and Landgraf M (2019) Target Selection Development of the Nervous System, 10.1016/B978-0-12-803996-0.00006-X, (159-193), . Luo C, Wang K and Zhang H (2017) Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study, BioMedical Engineering OnLine, 10.1186/s12938-017-0369-0, 16:1, Online publication date: 1-Dec-2017. Dorofeeva N, Ivanchenko D, Mashtalova O, Kulikova I, Chibineva S, Ter-Akopyan A, Sklyarov F and Kiyashko E (2017) SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE, Journal of Clinical Practice, 10.17816/clinpract8167-70, 8:1, (67-70) Diederichsen S, Darkner S, Chen X, Johannesen A, Pehrson S, Hansen J, Feldt-Rasmussen U and Svendsen J (2016) Short-term amiodarone treatment for atrial fibrillation after catheter ablation induces a transient thyroid dysfunction: Results from the placebo-controlled, randomized AMIO-CAT trial, European Journal of Internal Medicine, 10.1016/j.ejim.2016.04.012, 33, (36-41), Online publication date: 1-Sep-2016. Paudel R, Dogra P, Suman S, Acharya S and Matta J (2016) Acute Liver and Renal Failure: A Rare Adverse Effect Exclusive to Intravenous form of Amiodarone, Case Reports in Critical Care, 10.1155/2016/5232804, 2016, (1-4), . Lee J, Kang M, Kim T, Shin D, Choi R and Jung S (2015) A Case of Acute Hepatitis Associated with Intravenous Infusion Amiodarone in Patient with Atrial Fibrillation, Soonchunhyang Medical Science, 10.15746/sms.15.049, 21:2, (208-211) Karakurt A, Yildiz C, Yildiz A and Başbuğ H (2015) Amiodarone-induced exudative bullous lesion and hepatotoxicity in a patient with ventricular tachycardia, International Journal of the Cardiovascular Academy, 10.1016/j.ijcac.2015.10.003, 1:2-3, (62-65), Online publication date: 1-Sep-2015. Lafuente-Lafuente C, Valembois L, Bergmann J and Belmin J (2015) Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005049.pub4 Weipert K, Erkapic D and Schmitt J (2015) Frequenz- und Rhythmuskontrolle bei VorhofflimmernRate and rhythm control in atrial fibrillation, Herz, 10.1007/s00059-014-4201-3, 40:1, (16-24), Online publication date: 1-Feb-2015. CHUNG R, HOUGHTALING P, TCHOU M, NIEBAUER M, LINDSAY B, TCHOU P and CHUNG M (2014) Left Ventricular Hypertrophy and Antiarrhythmic Drugs in Atrial Fibrillation: Impact on Mortality, Pacing and Clinical Electrophysiology, 10.1111/pace.12426, 37:10, (1338-1348), Online publication date: 1-Oct-2014. Scheinfeld N, Chernoff K, Derek Ho M and Liu Y (2014) RETRACTED: Drug-induced photoallergic and phototoxic reactions – an update, Expert Opinion on Drug Safety, 10.1517/14740338.2014.885948, 13:3, (321-340), Online publication date: 1-Mar-2014. Nair K, Cameron D, Moravsky G and Butany J (2014) Arrhythmias and Hypertrophic Cardiomyopathy Cardiac Arrhythmias, 10.1007/978-1-4471-5316-0_19, (253-264), . White N and Lenz T (2013) Drug-Induced Photosensitivity and the Major Culprits, American Journal of Lifestyle Medicine, 10.1177/1559827613475575, 7:3, (189-191), Online publication date: 1-May-2013. (2012) Manage drug-induced photosensitivity through prevention and discontinuation of the causative agent once an event has occurred, Drugs & Therapy Perspectives, 10.1007/BF03262130, 28:10, (20-23), Online publication date: 1-Oct-2012. Wang J, Hwang B, Lin Y and Chen J (2012) Development of Refractory Ascites during Amiodarone Therapy in a Hemodialysis Patient with Nephrogenic and Cardiogenic Ascites, Renal Failure, 10.3109/0886022X.2012.705206, 34:8, (1033-1036), Online publication date: 1-Sep-2012. Lafuente-Lafuente C, Longas-Tejero M, Bergmann J, Belmin J and Lafuente-Lafuente C (2012) Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005049.pub3 Flanagan E, Harper C, St Louis E, Silber M and Josephs K (2012) Amiodarone-associated neuromyopathy: a report of four cases, European Journal of Neurology, 10.1111/j.1468-1331.2012.03678.x, 19:5, (e50-e51), Online publication date: 1-May-2012. (2012) Toxicity Pharmacokinetics and Metabolism in Drug Design, 10.1002/9783527645763.ch8, (159-208) Sanes D, Reh T and Harris W (2012) Target selection Development of the Nervous System, 10.1016/B978-0-12-374539-2.00010-0, (143-169), . Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J and Yancy C (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy, Circulation, 124:24, (e783-e831), Online publication date: 13-Dec-2011.Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J and Yancy C (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary, Circulation, 124:24, (2761-2796), Online publication date: 13-Dec-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J, Yancy C, Jacobs A, Smith S, Anderson J, Albert N, Buller C, Creager M, Ettinger S, Guyton R, Halperin J, Hochman J, Krumholz H, Kushner F, Nishimura R, Ohman E, Page R, Stevenson W, Tarkington L and Yancy C (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2011.10.020, 142:6, (e153-e203), Online publication date: 1-Dec-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J, Yancy C, Jacobs A, Smith S, Anderson J, Albert N, Buller C, Creager M, Ettinger S, Guyton R, Halperin J, Hochman J, Krumholz H, Kushner F, Nishimura R, Ohman E, Page R, Stevenson W, Tarkington L and Yancy C (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2011.10.019, 142:6, (1303-1338), Online publication date: 1-Dec-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J and Yancy C (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary, Journal of the American College of Cardiology, 10.1016/j.jacc.2011.10.825, 58:25, (2703-2738), Online publication date: 1-Dec-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J and Yancy C (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, 10.1016/j.jacc.2011.06.011, 58:25, (e212-e260), Online publication date: 1-Dec-2011. Drucker A and Rosen C (2011) Drug-Induced Photosensitivity, Drug Safety, 10.2165/11592780-000000000-00000, 34:10, (821-837), Online publication date: 1-Oct-2011. Stahli B and Schwab S (2010) Amiodarone-induced skin hyperpigmentation, QJM, 10.1093/qjmed/hcq131, 104:8, (723-724), Online publication date: 1-Aug-2011. Arkun A, Van Deusen S, Grau T and Birkhahn R (2010) Hepatic Dysfunction and Neurotoxicity in a Patient Receiving Long-Term Low-Dose Amiodarone Therapy, The Journal of Emergency Medicine, 10.1016/j.jemermed.2008.01.006, 38:3, (337-339), Online publication date: 1-Apr-2010. Maoz K, Dvash S, Brenner S and Brenner S (2009) Amiodarone-induced skin pigmentation and multiple basal-cell carcinomas, International Journal of Dermatology, 10.1111/j.1365-4632.2008.03819.x, 48:12, (1398-1400), Online publication date: 1-Dec-2009. Lafuente-Lafuente C, Alvarez J, Leenhardt A, Mouly S, Extramiana F, Caulin C, Funck-Brentano C and Bergmann J (2009) Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity, British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.2009.03381.x, 67:5, (511-519), Online publication date: 1-May-2009. Llanos L, Moreu R, Peiró A, Pascual S, Francés R, Such J, Horga J, Pérez-Mateo M and Zapater P (2009) Causality assessment of liver injury after chronic oral amiodarone intake, Pharmacoepidemiology and Drug Safety, 10.1002/pds.1709, 18:4, (291-300), Online publication date: 1-Apr-2009. Ryan M and Kennedy K (2009) Neurotoxic Effects of Pharmaceutical Agents V: Miscellaneous Agents Clinical Neurotoxicology, 10.1016/B978-032305260-3.50040-X, (382-400), . Weatherald J and Marrie T (2008) Pseudocyanosis: Drug-Induced Skin Hyperpigmentation Can Mimic Cyanosis, The American Journal of Medicine, 10.1016/j.amjmed.2008.01.029, 121:5, (385-386), Online publication date: 1-May-2008. (2008) Effect of Drugs on the Electrocardiogram Chou's Electrocardiography in Clinical Practice, 10.1016/B978-141603774-3.10021-8, (509-531), . Lafuente-Lafuente C, Mouly S, Longas-Tejero M, Bergmann J and Lafuente-Lafuente C (2007) Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005049.pub2 (2008) References Color Atlas of Local and Systemic Signs of Cardiovascular Disease, 10.1002/9780470692424.refs, (103-109) Iglesias P (2007) Repercusiones del tratamiento con amiodarona sobre la función tiroidea y su manejo actual, Endocrinología y Nutrición, 10.1016/S1575-0922(07)71465-1, 54:7, (354-370), Online publication date: 1-Aug-2007. Stein K and Scheinfeld N (2007) Drug-induced photoallergic and phototoxic reactions, Expert Opinion on Drug Safety, 10.1517/14740338.6.4.431, 6:4, (431-443), Online publication date: 1-Jul-2007. CHANDHOK S and SCHWARTZMAN D (2007) Amiodarone Therapy for Atrial Rhythm Control: Insights Gained From a Single Center Experience, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.2007.00847.x, 18:7, (714-718), Online publication date: 1-Jul-2007. Omeroglu G, Kalugina Y, Ersahin C and Wojcik E (2006) Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: Cytologic, histologic, and electronmicroscopic findings, Diagnostic Cytopathology, 10.1002/dc.20313, 34:5, (351-354), Online publication date: 1-May-2006. Consídera D, Marchiori E, Souza Jr. A, Zanetti G, Escuissato D, Gasparetto E, Araújo Neto C, Lima R, Xavier S and Pedrosa R (2006) A tomografia computadorizada de alta resolução na avaliação da toxicidade pulmonar por amiodarona, Radiologia Brasileira, 10.1590/S0100-39842006000200008, 39:2, (113-118), Online publication date: 1-Apr-2006. Okayasu K, Takeda Y, Kojima J, Yoshizawa A, Kobayashi N, Sugiyama H and Kudo K (2006) Amiodarone Pulmonary Toxicity: A Patient with Three Recurrences of Pulmonary Toxicity and Consideration of the Probable Risk for Relapse, Internal Medicine, 10.2169/internalmedicine.45.1800, 45:22, (1303-1307), . Yıldırım S, Tiker F, Cengiz N and Kılıçdağ H (2005) Recurrent Supraventricular Tachycardia in a Newborn Treated with Amiodarone: Is Hyperkalemia the Apparent Cause?, Pediatric Cardiology, 10.1007/s00246-005-1043-z, 26:6, (879-880), Online publication date: 1-Dec-2005. Krauser D, Segal A and Kligfield P (2005) Severe Ataxia Caused by Amiodarone, The American Journal of Cardiology, 10.1016/j.amjcard.2005.06.093, 96:10, (1463-1464), Online publication date: 1-Nov-2005. Yildirim S, Azak E, Varan B and Tokel K (2005) Unusual and Early Hyperglycemia Following Amiodarone Infusion in Two Infants, Pediatric Cardiology, 10.1007/s00246-004-0911-2, 26:5, (715-716), Online publication date: 1-Oct-2005. Yones S, O'Donoghue N, Palmer R, Menage H and Hawk J (2005) Persistent severe amiodarone-induced photosensitivity, Clinical and Experimental Dermatology, 10.1111/j.1365-2230.2005.01820.x, 30:5, (500-502), Online publication date: 1-Sep-2005. Damy T, Pousset F, Caplain H, Hulot J and Lechat P (2004) Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects, Fundamental and Clinical Pharmacology, 10.1046/j.1472-8206.2003.00216.x, 18:1, (113-123), Online publication date: 1-Feb-2004. Sato T, Takizawa T, Saito T, Kobayashi S, Hara Y and Nakaya H (2003) Amiodarone Inhibits Sarcolemmal but Not Mitochondrial K ATP Channels in Guinea Pig Ventricular Cells , Journal of Pharmacology and Experimental Therapeutics, 10.1124/jpet.103.055863, 307:3, (955-960), Online publication date: 1-Dec-2003. Ott M, Khoor A, Leventhal J, Paterick T and Burger C (2003) Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone*, Chest, 10.1378/chest.123.2.646, 123:2, (646-651), Online publication date: 1-Feb-2003. Williams B and Kim J (2003) Cardiovascular Drug Therapy in the Elderly: Theoretical and Practical Considerations, Drugs & Aging, 10.2165/00002512-200320060-00004, 20:6, (445-463), . FRISHMAN W, BROSNAN B, GROSSMAN M, DASGUPTA D and SUN D (2002) Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part II, Cardiology in Review, 10.1097/00045415-200209000-00005, 10:5, (285-300), Online publication date: 1-Sep-2002. Galilea A, García Sánchez M, Mata García M and Fugarolas G (2002) Hepatitis tóxica aguda de instauración precoz por amiodarona intravenosa, Gastroenterología y Hepatología, 10.1016/S0210-5705(02)70272-0, 25:6, (392-394), Online publication date: 1-Jan-2002. Poll L, May P, Koch J, Hetzel G, Heering P and Mödder U (2016) HRCT Findings of Amiodarone Pulmonary Toxicity: Clinical and Radiologic Regression, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/107424840100600311, 6:3, (307-311), Online publication date: 1-Sep-2001. Varró A, Takács J, Németh M, Hála O, Virág L, Iost N, Baláti B, Ágoston M, Vereckei A, Pastor G, Delbruyère M, Gautier P, Nisato D and Papp J (2009) Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone, British Journal of Pharmacology, 10.1038/sj.bjp.0704106, 133:5, (625-634), Online publication date: 1-Jul-2001. Budu C, Balas N, Nawrath H, Wegener J and Shainberg A Increased Cardiac Alpha-1-Adrenoceptor Density in Rats Following Treatment with Amiodarone, Journal of Basic and Clinical Physiology and Pharmacology, 10.1515/JBCPP.2001.12.1.33, 12:1 COX G, JOHNSON J, KINNEAR W and JOHNSTON I (2000) Amiodarone and the lung: wide variations in clinical practice, Respiratory Medicine, 10.1053/rmed.2000.0867, 94:11, (1130-1131), Online publication date: 1-Nov-2000. Watanabe Y and Kimura J (2009) Inhibitory effect of amiodarone on Na + /Ca 2+ exchange current in guinea-pig cardiac myocytes , British Journal of Pharmacology, 10.1038/sj.bjp.0703527, 131:1, (80-84), Online publication date: 1-Sep-2000. Lee S, Chang C, Lu M, Lee R, Cheng J, Hung C and Chen S (2000) Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting, The Annals of Thoracic Surgery, 10.1016/S0003-4975(00)01308-4, 70:1, (157-161), Online publication date: 1-Jul-2000. Bahadır S, Apaydın R, Çobanoılu , Kapıcıoılu Z, Özoran Y, Gökçe M and Alpay K (2000) Amiodarone pigmentation, eye and thyroid alterations, Journal of the European Academy of Dermatology and Venereology, 10.1046/j.1468-3083.2000.00039.x, 14:3, (194-195), Online publication date: 1-May-2000. Pía Iglesias G, Garrido Sanjuán J, Fernández Fernández F and Sesma Sánchez P (2000) Bronquiolitis obliterante con neumonía organizativa focal y amiodarona, Revista Clínica Española, 10.1016/S0014-2565(00)70634-5, 200:5, (290), Online publication date: 1-Jan-2000. Méndez M, Parera V, Enrı́quez de Salamanca R and Batlle A (1999) Amiodarone is a pharmacologically safe drug for porphyrias, General Pharmacology: The Vascular System, 10.1016/S0306-3623(98)00202-X, 32:2, (259-263), Online publication date: 1-Feb-1999. Seminara S and Daniels G (1998) Amiodarone and the Thyroid, Endocrine Practice, 10.4158/EP.4.1.48, 4:1, (48-57), Online publication date: 1-Jan-1998. ltoh K, Kato R and Hotta N (1998) A Case Report of Myolysis During High-Dose Amiodarone Therapy for Uncontrolled Ventricular Tachycardia, Japanese Circulation Journal, 10.1253/jcj.62.305, 62:4, (305-308), . Daoud E, Strickberger S, Man K, Goyal R, Deeb G, Bolling S, Pagani F, Bitar C, Meissner M and Morady F (1997) Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery, New England Journal of Medicine, 10.1056/NEJM199712183372501, 337:25, (1785-1791), Online publication date: 18-Dec-1997. Tavackoli S, Stouffer G, Sheahan R, Runge M, Stouffer G and Sheahan R (1997) Amiodarone-Induced Thyrotoxicosis, The American Journal of the Medical Sciences, 10.1097/00000441-199708000-00011, 314:2, (97-100), Online publication date: 1-Aug-1997. Vorperian V, Havighurst T, Miller S and January C (1997) Adverse Effects of Low Dose Amiodarone: A Meta-Analysis, Journal of the American College of Cardiology, 10.1016/S0735-1097(97)00220-9, 30:3, (791-798), Online publication date: 1-Jul-1997. Tavackoli S, Stouffer G and Sheahan R (1997) The Effect of Nonsteroidal Antiinflammatory Drugs on Electrolyte Homeostasis and Blood Pressure in Young and Elderly Persons With and Without Renal Insufficiency, The American Journal of the Medical Sciences, 10.1016/S0002-9629(15)40175-2, 314:2, (97-100), Online publication date: 1-Jul-1997. Lee K and Tai Y (1997) Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: Efficacy and safety, Clinical Cardiology, 10.1002/clc.4960200414, 20:4, (372-377), Online publication date: 1-Apr-1997. Spirito P, Seidman C, McKenna W and Maron B (1997) The Management of Hypertrophic Cardiomyopathy, New England Journal of Medicine, 10.1056/NEJM199703133361107, 336:11, (775-785), Online publication date: 13-Mar-1997. Julian D, Camm A, Frangin G, Janse M, Munoz A, Schwartz P and Simon P (1997) Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT, The Lancet, 10.1016/S0140-6736(96)09145-3, 349:9053, (667-674), Online publication date: 1-Mar-1997. Hayashi K, Sone T, Suzuki T, Numaguchi Y, Kondoh J, Tsuboi H and Sassa H (1997) A Case of Amiodarone-Induced Thyrotoxicosis Successfully Treated With Prednisolone, Japanese Circulation Journal, 10.1253/jcj.61.361, 61:4, (361-366), . Cameron R, de la Iglesia F and Feuer G (1996) Hepatotoxicity of Cardiovascular Drugs Drug-Induced Hepatotoxicity, 10.1007/978-3-642-61013-4_21, (477-513), . Pirmohamed M and Park B (1996) Mechanisms of Hypertransaminemia Drug-Induced Hepatotoxicity, 10.1007/978-3-642-61013-4_18, (411-440), . Gould J, Mercurio M and Elmets C (1995) Cutaneous photosensitivity diseases induced by exogenous agents, Journal of the American Academy of Dermatology, 10.1016/0190-9622(95)91271-1, 33:4, (551-573), Online publication date: 1-Oct-1995. Monk B (2006) Basal cell carcinoma following amiodarone therapy, British Journal of Dermatology, 10.1111/j.1365-2133.1995.tb02515.x, 133:1, (148-149) Tisdale J, Follin S, Ordelova A and Webb C (2013) Risk Factors for the Development of Specific Noncardiovascular Adverse Effects Associated With Amiodarone, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1995.tb04072.x, 35:4, (351-356), Online publication date: 1-Apr-1995. Sun D, Reiner D, Frishman W, Grossman M and Luftschein S (2013) Adverse Dermatologic Reactions from Antiarrhythmic Drug Therapy, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1994.tb01966.x, 34:10, (953-966), Online publication date: 1-Oct-1994. DOOTSON G and BYATT C (1994) Amiodarone-induced vasculitis and a review of the cutaneous side-effects of amiodarone, Clinical and Experimental Dermatology, 10.1111/j.1365-2230.1994.tb02701.x, 19:5, (422-424), Online publication date: 1-Sep-1994. Shukla R, Jowett N, Thompson D and Pohl J (1994) Side effects with amiodarone therapy, Postgraduate Medical Journal, 10.1136/pgmj.70.825.492, 70:825, (492-498), Online publication date: 1-Jul-1994. Stewart J and McKenna W (1994) Management of arrhythmias in hypertrophic cardiomyopathy, Cardiovascular Drugs and Therapy, 10.1007/BF00877095, 8:1, (95-99), Online publication date: 1-Feb-1994. HAWTHORNE H, WOOD M, STAMBLER B, DAMIANO R and ELLENBOGEN K (1993) Can Amiodarone Pulmonary Toxicity Be Predicted in Patients Undergoing Implantable Cardioverter Defibrillator Implantation?, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.1993.tb02330.x, 16:12, (2241-2249), Online publication date: 1-Dec-1993. Camm A, Julian D, Janse G, Munoz A, Schwartz P, Simon P and Frangin G (1993) The European Myocardial Infarct Amiodarone Trial (EMIAT), The American Journal of Cardiology, 10.1016/0002-9149(93)90970-N, 72:16, (F95-F98), Online publication date: 1-Nov-1993. Cairns J, Connolly S, Roberts R and Gent M (1993) Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): Rationale and protocol, The American Journal of Cardiology, 10.1016/0002-9149(93)90969-J, 72:16, (F87-F94), Online publication date: 1-Nov-1993. Middlekauff H, Wiener I and Stevenson W (1993) Low-dose amiodarone for atrial fibrillation, The American Journal of Cardiology, 10.1016/0002-9149(93)90967-H, 72:16, (F75-F81), Online publication date: 1-Nov-1993. Nademanee K, Singh B, Stevenson W and Weiss J (1993) Amiodarone and post-MI patients., Circulation, 88:2, (764-774), Online publication date: 1-Aug-1993. Butler J, Harriss D, Sinclair M and Westaby S (1993) Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial., Heart, 10.1136/hrt.70.1.56, 70:1, (56-60), Online publication date: 1-Jul-1993. McComb J (1993) Safety of antiarrhythmic drugs in children., Heart, 10.1136/hrt.70.1.13, 70:1, (13-14), Online publication date: 1-Jul-1993. Rhodes A, Eastwood J and Smith S (1993) Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?, Gut, 10.1136/gut.34.4.565, 34:4, (565-566), Online publication date: 1-Apr-1993. Lee K, Tsai T and Lee E (1993) Membrane activity of class III antiarrhythmic compounds; a comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide, European Journal of Pharmacology, 10.1016/0014-2999(93)90704-L, 234:1, (43-53), Online publication date: 1-Mar-1993. DELANY S, TAYLOR D, RESTIEAUX N and DOYLE T (1993) Amiodarone pulmonary toxicity: its radiological features, Australasian Radiology, 10.1111/j.1440-1673.1993.tb00006.x, 37:1, (47-49), Online publication date: 1-Feb-1993. Stewart J and McKenna W (1993) Haemodynamic Disorders: Management and Prognosis Cardiomyopathies, 10.1007/978-3-642-77598-7_9, (108-143), . Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, Kuch J, Nartowicz E, Smielak-Korombel J, Dyduszynski A, Maciejewicz J, Zaleska T, Lazarczyk-Kedzia E, Motyka J, Paczkowska B, Sczaniecka O and Yusuf S (1992) Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study, Journal of the American College of Cardiology, 10.1016/0735-1097(92)90357-S, 20:5, (1056-1062), Online publication date: 1-Nov-1992. Kodama I, Suzuki R, Kamiya K, Iwata H and Toyama J (2012) Effects of long-term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle, British Journal of Pharmacology, 10.1111/j.1476-5381.1992.tb12774.x, 107:2, (502-509), Online publication date: 1-Oct-1992. Carvalho J and Rigby M (1992) Hypertrophic cardiomyopathy, Progress in Pediatric Cardiology, 10.1016/1058-9813(92)90032-H, 1:4, (48-60), Online publication date: 1-Sep-1992. Lüderitz B and Manz M (1992) Pharmacologic treatment of supraventricular tachycardia: The German experience, The American Journal of Cardiology, 10.1016/0002-9149(92)91081-E, 70:5, (A66-A74), Online publication date: 1-Aug-1992. Crozier I (1992) Flecainide in the Wolff-Parkinson-White syndrome, The American Journal of Cardiology, 10.1016/0002-9149(92)91074-E, 70:5, (A26-A32), Online publication date: 1-Aug-1992. NATTEL S, TALAJIC M, FERMINI B and ROY D (1992) Amiodarone: Pharmacology, Clinical Actions, and Relationships Between Them, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.1992.tb0097
Referência(s)